Examining Bluetooth Haptic Device Use for Pain and Anxiety Reduction in Vascular Access Procedures
Launched by STANFORD UNIVERSITY · Jan 22, 2024
Trial Information
Current as of November 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the use of a special vibrating device to help reduce pain and anxiety in children and young adults during procedures where they need a needle inserted, like drawing blood or placing an IV. Researchers want to see if this device can make these experiences less stressful for patients.
To participate, individuals need to be between the ages of 4 and 99 and scheduled for a vascular access procedure. They should also be able to speak English, as well as their parent or guardian. However, some children may not be eligible if they have certain medical conditions or if their guardian cannot be present to provide consent. Participants in the study can expect to use the vibrating device during their procedure, and the goal is to help make the process easier and more comfortable for them. If you're considering this trial for your child, it could offer a way to improve their experience during medical procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between age 4-99
- • Will undergo a vascular access procedure
- • English speaking participant and parent or LAR
- Exclusion Criteria:
- • Legal guardian not present to obtain consent
- • Child is unable to self-report pain or anxiety
- • Child with a significant neurological condition, or major developmental disability
- • Child with active infection of the hand or arm
- • Major surgery within the last 48 hours
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Thomas Caruso, MD,PhD
Study Director
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported